BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18181189)

  • 41. Lack of generalizability of sensitivity and specificity with treatment effects.
    Dodd LE; Korn EL
    Stat Med; 2008 May; 27(10):1734-44. PubMed ID: 17940996
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer.
    Ding L; Zou XJ; Ao JE; Yao AX; Cai L
    Mol Diagn Ther; 2008; 12(6):395-400. PubMed ID: 19035626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of fluorescence threshold triggering and high-speed flow cytometry for rare event detection.
    Rehse MA; Corpuz S; Heimfeld S; Minie M; Yachimiak D
    Cytometry; 1995 Dec; 22(4):317-22. PubMed ID: 8749782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rare-cell detector for cancer.
    Krivacic RT; Ladanyi A; Curry DN; Hsieh HB; Kuhn P; Bergsrud DE; Kepros JF; Barbera T; Ho MY; Chen LB; Lerner RA; Bruce RH
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10501-4. PubMed ID: 15249663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison of 2 methods of flow cytofluorometric analysis of epithelial cells in the diagnosis of uterine cervix cancer].
    Popova ON; Orekhov AN; Semavin IE; Mikhaĭlova NA; Belousova TV
    Lab Delo; 1987; (9):659-62. PubMed ID: 2447359
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of fixation on RNA integrity in a liquid-based cervical cytology setting.
    Horvath CA; Boulet G; Sahebali S; Depuydt C; Vermeulen T; Vanden Broeck D; Vereecken A; Bogers J
    J Clin Pathol; 2008 Jan; 61(1):132-7. PubMed ID: 17468293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents.
    Muehlbauer PA; Schuler MJ
    Mutat Res; 2005 Aug; 585(1-2):156-69. PubMed ID: 15996509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: evidence for down-regulation in cervical cancer.
    Kimmig R; Pfeiffer D; Landsmann H; Hepp H
    Int J Cancer; 1997 Aug; 74(4):365-73. PubMed ID: 9291423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescreening of cervical smears using two-parameter flow cytometry. Cytologic identification of artifacts.
    Gieseking F; Baisch H; Scholz KU; Stegner HE; Linden WA
    Anal Quant Cytol; 1981 Dec; 3(4):299-304. PubMed ID: 7332158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis.
    Krishan A; Ganjei-Azar P; Jorda M; Hamelik RM; Reis IM; Nadji M
    Diagn Cytopathol; 2006 Aug; 34(8):528-41. PubMed ID: 16850481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Automated image cytometry in cytopathology.
    Ploem JS
    Verh Dtsch Ges Pathol; 1990; 74():169-75. PubMed ID: 1708578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A handheld device for potential point-of-care screening of cancer.
    Kang CC; Chang CC; Chang TC; Liao LJ; Lou PJ; Xie W; Yeung ES
    Analyst; 2007 Aug; 132(8):745-9. PubMed ID: 17646873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uses and future applications of flow cytometry in immunotoxicity testing.
    Burchiel SW; Lauer FT; Gurulé D; Mounho BJ; Salas VM
    Methods; 1999 Sep; 19(1):28-35. PubMed ID: 10525435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-throughput screening with HyperCyt flow cytometry to detect small molecule formylpeptide receptor ligands.
    Young SM; Bologa C; Prossnitz ER; Oprea TI; Sklar LA; Edwards BS
    J Biomol Screen; 2005 Jun; 10(4):374-82. PubMed ID: 15964939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
    Nückel H; Novotny JR; Noppeney R; Savidou I; Dührsen U
    Clin Lab Haematol; 2006 Feb; 28(1):22-9. PubMed ID: 16430456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Application of flow-type analyzers in oncology].
    Pinchuk VG; Isakov VL; Mazur LA
    Vopr Onkol; 1983; 29(8):75-83. PubMed ID: 6351430
    [No Abstract]   [Full Text] [Related]  

  • 57. Rare-event analysis in flow cytometry.
    Donnenberg AD; Donnenberg VS
    Clin Lab Med; 2007 Sep; 27(3):627-52, viii. PubMed ID: 17658410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [DNA multiparametric analysis by flow cytometry of cancer of the uterine cervix].
    Kornovski Ia; Balev S; Ivanova F
    Akush Ginekol (Sofiia); 2002; 42(1):32-5. PubMed ID: 11935698
    [No Abstract]   [Full Text] [Related]  

  • 59. Flow cytometric enrichment for respiratory epithelial cells in sputum.
    Kraemer PS; Sanchez CA; Goodman GE; Jett J; Rabinovitch PS; Reid BJ
    Cytometry A; 2004 Jul; 60(1):1-7. PubMed ID: 15229852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new technique for detecting fluorescently labelled cells at very low densities.
    Sheldon KM; Sheldon RW
    Anticancer Res; 1993; 13(2):459-66. PubMed ID: 8517663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.